G-protein coupled receptor 30 Rabbit Polyclonal Antibody
cat.: ER1803-90
Product Type: Rabbit polyclonal IgG, primary antibodies
Species reactivity: Human
Applications: IF-Cell, FC
Clonality: Polyclonal
Form: Liquid
Storage condition: Shipped at 4℃. Store at +4℃ short term (1-2 weeks). It is recommended to aliquot into single-use upon delivery. Store at -20℃ long term.
Storage buffer: 1*PBS (pH7.4), 0.2% BSA, 50% Glycerol. Preservative: 0.05% Sodium Azide.
Concentration: 1ug/ul
Purification: Immunogen affinity purified.
Molecular weight: Predicted band size: 42 kDa
Isotype: IgG
Immunogen: Recombinant protein within Human G-protein coupled receptor 30 aa 236-375 / 375.
Positive control: LoVo, SH-SY5Y.
Subcellular location: Mitochondrion,Nucleus,Endosome,Golgi apparatus,Endoplasmic reticulum,Cytoskeleton.
Recommended Dilutions:
  IF-Cell
  FC

1:100
1:1,000
Uniprot #: SwissProt: Q99527 Human
Alternative names: CEPR Chemoattractant receptor-like 2 Chemokine receptor-like 2 CMKRL2 Constitutively expressed peptide like receptor DRY12 FEG 1 FEG-1 Flow-induced endothelial G protein-coupled receptor Flow-induced endothelial G-protein coupled receptor 1 G protein-coupled receptor 30 G-protein coupled estrogen receptor 1 G-protein coupled receptor 30 GPCR-BR Gper GPER_HUMAN GPER1 GPR30 IL8-related receptor DRY12 Lergu LERGU2 leucine rich protein in GPR30 3'UTR LYGPR Lymphocyte-derived G-protein coupled receptor Membrane estrogen receptor mER MGC99678
Images
ER1803-90_1.jpg Fig1: Immunocytochemistry analysis of LoVo cells labeling G-protein coupled receptor 30 with Rabbit anti-G-protein coupled receptor 30 antibody (ER1803-90) at 1/100 dilution.

Cells were fixed in 4% paraformaldehyde for 15 minutes at room temperature, permeabilized with 0.1% Triton X-100 in PBS for 15 minutes at room temperature, then blocked with 1% BSA in 10% negative goat serum for 1 hour at room temperature. Cells were then incubated with Rabbit anti-G-protein coupled receptor 30 antibody (ER1803-90) at 1/100 dilution in 1% BSA in PBST overnight at 4 ℃. Goat Anti-Rabbit IgG H&L (iFluor™ 488, HA1121) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI.

Beta tubulin (M1305-2, red) was stained at 1/100 dilution overnight at +4℃. Goat Anti-Mouse IgG H&L (iFluor™ 594, HA1126) was used as the secondary antibody at 1/1,000 dilution.
ER1803-90_2.jpg Fig2: Immunocytochemistry analysis of SH-SY5Y cells labeling G-protein coupled receptor 30 with Rabbit anti-G-protein coupled receptor 30 antibody (ER1803-90) at 1/100 dilution.

Cells were fixed in 4% paraformaldehyde for 15 minutes at room temperature, permeabilized with 0.1% Triton X-100 in PBS for 15 minutes at room temperature, then blocked with 1% BSA in 10% negative goat serum for 1 hour at room temperature. Cells were then incubated with Rabbit anti-G-protein coupled receptor 30 antibody (ER1803-90) at 1/100 dilution in 1% BSA in PBST overnight at 4 ℃. Goat Anti-Rabbit IgG H&L (iFluor™ 488, HA1121) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI.

Beta tubulin (M1305-2, red) was stained at 1/100 dilution overnight at +4℃. Goat Anti-Mouse IgG H&L (iFluor™ 594, HA1126) was used as the secondary antibody at 1/1,000 dilution.
ER1803-90_3.jpg Fig3: Flow cytometric analysis of SH-SY5Y cells labeling G-protein coupled receptor 30.

Cells were fixed and permeabilized. Then stained with the primary antibody (ER1803-90, 1/1,000) (red) compared with Rabbit IgG Isotype Control (green). After incubation of the primary antibody at +4℃ for an hour, the cells were stained with a iFluor™ 488 conjugate-Goat anti-Rabbit IgG Secondary antibody (HA1121) at 1/1,000 dilution for 30 minutes at +4℃. Unlabelled sample was used as a control (cells without incubation with primary antibody; black).
Note: All products are “FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE”.